Procept biorobotics announces new cpt® category i code from the american medical association for aquablation therapy

San jose, calif., june 17, 2024 (globe newswire) -- procept biorobotics® corporation (nasdaq: prct) (the “company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that the american medical association (“ama”) has established a new current procedural terminology (“cpt”) category i code for transurethral waterjet resection of prostate tissue (“aquablation therapy”) to treat benign prostatic hyperplasia (“bph”).
CPT Ratings Summary
CPT Quant Ranking